HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation

Abstract Idiopathic pulmonary fibrosis (IPF) is a life-threatening interstitial lung disease. Identifying biomarkers for early diagnosis is of great clinical importance. The epididymis protein 4 (HE4) is important in the process of inflammation and fibrosis in the epididymis. Its prognostic value in...

Full description

Bibliographic Details
Main Authors: Mi Tian, Xiaohui Zhu, Lijun Ren, Xuan Zhou, Lina GU, Kaifang Meng, Yaqiong Tian, Hourong Cai, Xiaoqin Liu, Jingjing Ding
Format: Article
Language:English
Published: BMC 2024-04-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-024-01829-0
_version_ 1797199547105017856
author Mi Tian
Xiaohui Zhu
Lijun Ren
Xuan Zhou
Lina GU
Kaifang Meng
Yaqiong Tian
Hourong Cai
Xiaoqin Liu
Jingjing Ding
author_facet Mi Tian
Xiaohui Zhu
Lijun Ren
Xuan Zhou
Lina GU
Kaifang Meng
Yaqiong Tian
Hourong Cai
Xiaoqin Liu
Jingjing Ding
author_sort Mi Tian
collection DOAJ
description Abstract Idiopathic pulmonary fibrosis (IPF) is a life-threatening interstitial lung disease. Identifying biomarkers for early diagnosis is of great clinical importance. The epididymis protein 4 (HE4) is important in the process of inflammation and fibrosis in the epididymis. Its prognostic value in IPF, however, has not been studied. The mRNA and protein levels of HE4 were used to determine the prognostic value in different patient cohorts. In this study, prognostic nomograms were generated based on the results of the cox regression analysis. We identified the HE4 protein level increased in IPF patients, but not the HE4 gene expression. The increased expression of HE4 correlated positively with a poor prognosis for patients with IPF. The HR and 95% CI were 2.62 (1.61–4.24) (p < 0.001) in the training set. We constructed a model based on the risk-score = 0.16222182 * HE4 + 0/0.37580659/1.05003609 (for GAP index 0–3/4–5/6–8) + (− 1.1183375). In both training and validation sets, high-risk patients had poor prognoses (HR: 3.49, 95%CI 2.10–5.80, p = 0.001) and higher likelihood of dying (HR: 6.00, 95%CI 2.04–17.67, p = 0.001). Analyses of calibration curves and decision curves suggest that the method is effective in predicting outcomes. Furthermore, a similar formulation was used in a protein-based model based on HE4 that also showed prognostic value when applied to IPF patients. Accordingly, HE4 is an independent poor prognosis factor, and it has the potential to predict IPF patient survival.
first_indexed 2024-04-24T07:17:29Z
format Article
id doaj.art-794993b31d7b4897a82e510aeb5f0876
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-04-24T07:17:29Z
publishDate 2024-04-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-794993b31d7b4897a82e510aeb5f08762024-04-21T11:13:00ZengBMCEuropean Journal of Medical Research2047-783X2024-04-0129111110.1186/s40001-024-01829-0HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validationMi Tian0Xiaohui Zhu1Lijun Ren2Xuan Zhou3Lina GU4Kaifang Meng5Yaqiong Tian6Hourong Cai7Xiaoqin Liu8Jingjing Ding9Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolDepartment of Respiratory, The Fourth Affiliated Hospital of Nanjing Medical UniversityDepartment of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese MedicineDepartment of Respiratory, The Fourth Affiliated Hospital of Nanjing Medical UniversityDepartment of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical UniversityDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolDepartment of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolAbstract Idiopathic pulmonary fibrosis (IPF) is a life-threatening interstitial lung disease. Identifying biomarkers for early diagnosis is of great clinical importance. The epididymis protein 4 (HE4) is important in the process of inflammation and fibrosis in the epididymis. Its prognostic value in IPF, however, has not been studied. The mRNA and protein levels of HE4 were used to determine the prognostic value in different patient cohorts. In this study, prognostic nomograms were generated based on the results of the cox regression analysis. We identified the HE4 protein level increased in IPF patients, but not the HE4 gene expression. The increased expression of HE4 correlated positively with a poor prognosis for patients with IPF. The HR and 95% CI were 2.62 (1.61–4.24) (p < 0.001) in the training set. We constructed a model based on the risk-score = 0.16222182 * HE4 + 0/0.37580659/1.05003609 (for GAP index 0–3/4–5/6–8) + (− 1.1183375). In both training and validation sets, high-risk patients had poor prognoses (HR: 3.49, 95%CI 2.10–5.80, p = 0.001) and higher likelihood of dying (HR: 6.00, 95%CI 2.04–17.67, p = 0.001). Analyses of calibration curves and decision curves suggest that the method is effective in predicting outcomes. Furthermore, a similar formulation was used in a protein-based model based on HE4 that also showed prognostic value when applied to IPF patients. Accordingly, HE4 is an independent poor prognosis factor, and it has the potential to predict IPF patient survival.https://doi.org/10.1186/s40001-024-01829-0IPFHE4Clinical prediction modelGAP index
spellingShingle Mi Tian
Xiaohui Zhu
Lijun Ren
Xuan Zhou
Lina GU
Kaifang Meng
Yaqiong Tian
Hourong Cai
Xiaoqin Liu
Jingjing Ding
HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation
European Journal of Medical Research
IPF
HE4
Clinical prediction model
GAP index
title HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation
title_full HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation
title_fullStr HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation
title_full_unstemmed HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation
title_short HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation
title_sort he4 based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis construction and validation
topic IPF
HE4
Clinical prediction model
GAP index
url https://doi.org/10.1186/s40001-024-01829-0
work_keys_str_mv AT mitian he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT xiaohuizhu he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT lijunren he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT xuanzhou he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT linagu he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT kaifangmeng he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT yaqiongtian he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT hourongcai he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT xiaoqinliu he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation
AT jingjingding he4basednomogramforpredictingoverallsurvivalinpatientswithidiopathicpulmonaryfibrosisconstructionandvalidation